The pharmaceutical landscape is witnessing a paradigm shift from traditional protein-based vaccines toward genetic immunization. The Deoxyribonucleic Acid (Dna) Vaccines Market represents a frontier in biotechnology, offering a platform that is faster to manufacture, more stable at ambient temperatures, and capable of triggering both humoral and cellular immune responses. https://www.databridgemarketresearch.com/